Psychiatric Nursing 3
- Rois Narvaez
- 6 days ago
- 27 min read
š Psychiatric Medications & Therapies ā Introduction
Psychopharmacology and psychiatric therapies are essential components of modern mental health treatment aimed at stabilizing mood, reducing psychosis, controlling anxiety, improving cognition, preventing relapse, and promoting long-term psychosocial functioning. Psychiatric medications alter neurotransmitter activity involving serotonin, dopamine, norepinephrine, GABA, acetylcholine, and glutamate pathways to improve symptoms affecting mood, perception, thought process, behavior, sleep, and impulse control. Psychiatric therapies complement pharmacologic management by improving coping, emotional regulation, insight, communication, trauma processing, behavior modification, stress management, relapse prevention, and recovery-oriented functioning. Safe psychiatric care requires continuous monitoring for medication toxicity, suicide risk, extrapyramidal symptoms, metabolic syndrome, serotonin syndrome, withdrawal syndromes, adherence barriers, and psychosocial stressors while integrating interdisciplinary, patient-centered, and trauma-informed approaches across inpatient, outpatient, and community settings.
1ļøā£0ļøā£1ļøā£ š Antidepressants Overview
š§ Pathophysiology & Core Concepts
š· Antidepressants regulate serotonin, norepinephrine, dopamine pathways
š· Used depression, anxiety, OCD, PTSD disorders
š· Therapeutic effect delayed 2ā6 weeks commonly
š· Early energy improvement may ā suicide risk
š· Abrupt discontinuation may cause withdrawal symptoms
š· Medication selection depends symptoms/comorbidities profile
š Monitoring & Adverse Effects
š· SSRIs: nausea, insomnia, sexual dysfunction common
š· SNRIs may increase BP and HR
š· TCAs cause anticholinergic and cardiac effects
š· MAOIs risk hypertensive crisis with tyramine
š· Serotonin syndrome: fever, clonus, agitation, diarrhea
š· Monitor mood, sleep, appetite, suicidality trends
š Medication Examples & Management
š· SSRIs: sertraline, fluoxetine, escitalopram
š· SNRIs: venlafaxine, duloxetine
š· TCAs: amitriptyline, imipramine
š· MAOIs: phenelzine, tranylcypromine
š· Atypicals: bupropion, mirtazapine, trazodone
š· Gradual taper prevents discontinuation syndrome
𩺠Nursing & Collaborative Management
š· Teach delayed onset and adherence importance
š· Monitor suicide risk especially early therapy
š· Avoid alcohol and serotonergic drug combinations
š· Encourage morning dosing if insomnia occurs
š· Teach MAOI dietary restrictions thoroughly
š· Collaborate psychiatry/pharmacy for adverse-effect monitoring
1ļøā£0ļøā£2ļøā£ š Selective Serotonin Reuptake Inhibitors (SSRIs)
š§ Pathophysiology & Core Concepts
š· SSRIs increase serotonin availability at synapse
š· First-line many depression/anxiety disorders
š· Safer overdose profile than TCAs
š· May initially worsen anxiety temporarily
š· Sexual dysfunction common long-term issue
š· Black box suicidality warning younger patients
š Monitoring & Adverse Effects
š· GI upset and headache commonly occur
š· Insomnia or sedation varies by medication
š· Hyponatremia possible older adults
š· Serotonin syndrome risk with polypharmacy
š· Bleeding risk ā with NSAIDs/anticoagulants
š· Monitor mood activation or mania emergence
š Medication Examples & Management
š· Fluoxetine activating longer half-life SSRI
š· Sertraline common depression/PTSD treatment option
š· Escitalopram well-tolerated anxiety/depression medication
š· Paroxetine causes more anticholinergic effects
š· Fluvoxamine commonly used OCD treatment
š· Gradual taper reduces withdrawal symptoms
𩺠Nursing & Collaborative Management
š· Teach effects may take several weeks
š· Monitor for worsening depression/suicidal thoughts
š· Encourage taking consistently same time daily
š· Report fever, rigidity, severe agitation immediately
š· Avoid abrupt discontinuation without provider guidance
š· Collaborate psychiatry for dose adjustments
1ļøā£0ļøā£3ļøā£ š Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
š§ Pathophysiology & Core Concepts
š· Increase serotonin and norepinephrine neurotransmission
š· Effective depression and anxiety disorder treatment
š· Helpful chronic pain and neuropathy conditions
š· Norepinephrine effects may improve energy/concentration
š· Withdrawal symptoms significant if abruptly stopped
š· May increase BP due norepinephrine effects
š Monitoring & Adverse Effects
š· Nausea, sweating, insomnia common side effects
š· BP ā especially high-dose venlafaxine therapy
š· Sexual dysfunction may occur similarly SSRIs
š· Anxiety/agitation possible treatment initiation period
š· Monitor serotonin syndrome symptoms closely
š· Assess liver function with duloxetine use
š Medication Examples & Management
š· Venlafaxine used depression/anxiety/panic disorders
š· Duloxetine treats depression and neuropathic pain
š· Desvenlafaxine active venlafaxine metabolite option
š· Levomilnacipran more norepinephrine-focused SNRI
š· Gradual taper prevents discontinuation symptoms
š· Avoid MAOIs within recommended washout period
𩺠Nursing & Collaborative Management
š· Monitor BP and pulse routinely
š· Teach avoid abrupt medication discontinuation
š· Encourage adherence despite delayed improvement onset
š· Assess mood, energy, sleep pattern changes
š· Report severe headache or hypertension symptoms
š· Collaborate provider regarding dose titration plans
1ļøā£0ļøā£4ļøā£ š Tricyclic Antidepressants (TCAs)
š§ Pathophysiology & Core Concepts
š· Block serotonin and norepinephrine reuptake
š· Older antidepressants with significant side effects
š· Anticholinergic effects common due receptor blockade
š· Highly dangerous in overdose situations
š· Sometimes used chronic pain and migraine prevention
š· Sedation may benefit insomnia symptoms
š Monitoring & Adverse Effects
š· Dry mouth, constipation, urinary retention common
š· Orthostatic hypotension increases fall risk
š· Sedation and weight gain may occur
š· Cardiotoxicity causes dysrhythmias/QRS widening overdose
š· Elderly highly sensitive anticholinergic confusion effects
š· ECG monitoring important high-risk patients
š Medication Examples & Management
š· Amitriptyline highly sedating TCA option
š· Imipramine sometimes used enuresis treatment
š· Nortriptyline less anticholinergic compared amitriptyline
š· Clomipramine effective OCD treatment medication
š· Overdose may require sodium bicarbonate therapy
š· Gradual dose titration improves tolerability
𩺠Nursing & Collaborative Management
š· Teach rise slowly to prevent falls
š· Encourage fluid/fiber intake constipation prevention
š· Monitor suicidal overdose risk carefully
š· Avoid alcohol and CNS depressants
š· Assess ECG and cardiac history before therapy
š· Collaborate provider regarding toxicity symptoms promptly
1ļøā£0ļøā£5ļøā£ š Monoamine Oxidase Inhibitors (MAOIs)
š§ Pathophysiology & Core Concepts
š· Inhibit monoamine oxidase neurotransmitter breakdown enzyme
š· Increase serotonin, norepinephrine, dopamine levels
š· Effective atypical or treatment-resistant depression
š· Tyramine interaction may trigger hypertensive crisis
š· Significant drug interactions require careful monitoring
š· Washout periods essential between antidepressants
š Monitoring & Adverse Effects
š· Orthostatic hypotension common side effect
š· Weight gain and sexual dysfunction possible
š· Hypertensive crisis: severe headache, BP ā, diaphoresis
š· Serotonin syndrome risk with serotonergic medications
š· Insomnia and agitation may occur
š· Monitor adherence to dietary restrictions carefully
š Medication Examples & Management
š· Phenelzine classic MAOI antidepressant medication
š· Tranylcypromine more activating MAOI option
š· Selegiline transdermal patch lower dietary restrictions
š· Avoid aged cheese, wine, cured meats
š· 14-day washout before starting SSRIs/SNRIs
š· Hypertensive crisis requires emergency treatment immediately
𩺠Nursing & Collaborative Management
š· Teach strict tyramine-restricted diet adherence
š· Review OTC medications for interactions carefully
š· Monitor BP and headache complaints closely
š· Teach emergency signs hypertensive crisis
š· Reinforce medication washout importance strongly
š· Collaborate pharmacy regarding interaction prevention
1ļøā£0ļøā£6ļøā£ ā ļø Serotonin Syndrome
š§ Pathophysiology & Risk Factors
š· Excess serotonin activity within CNS and periphery
š· Usually caused medication interaction or overdose
š· SSRIs, MAOIs, tramadol commonly implicated
š· Rapid onset often within hours exposure
š· Polypharmacy significantly increases syndrome risk
š· Untreated severe cases may become fatal
š Clinical Manifestations & Assessment
š· Triad: mental-status changes, autonomic instability, neuromuscular hyperactivity
š· Agitation, confusion, anxiety commonly occur
š· Hyperthermia and diaphoresis significant findings
š· Hyperreflexia and clonus hallmark neuromuscular signs
š· Tachycardia, hypertension, diarrhea may occur
š· Severe rigidity may progress rhabdomyolysis
š Medical / Emergency Management
š· Stop serotonergic medications immediately
š· Supportive care and IV fluids essential
š· Benzodiazepines reduce agitation and muscle activity
š· Cyproheptadine serotonin antagonist severe cases
š· Cooling measures treat hyperthermia aggressively
š· ICU care needed severe autonomic instability
𩺠Nursing & Collaborative Management
š· Recognize symptoms early and report immediately
š· Monitor VS, temperature, rigidity, LOC closely
š· Assess medication combinations carefully always
š· Avoid restraining severely hyperthermic patient unnecessarily
š· Educate patients avoid self-mixing serotonergic drugs
š· Collaborate emergency and critical-care teams urgently
1ļøā£0ļøā£7ļøā£ š Antipsychotics Overview
š§ Pathophysiology & Core Concepts
š· Antipsychotics mainly block dopamine receptors
š· Used schizophrenia, mania, severe agitation treatment
š· FGAs higher EPS risk than SGAs
š· SGAs associated metabolic syndrome complications
š· Clozapine reserved refractory psychotic disorders
š· Long-acting injectables improve medication adherence
š Monitoring & Adverse Effects
š· Sedation and orthostatic hypotension common
š· EPS: dystonia, akathisia, parkinsonism possible
š· Tardive dyskinesia may develop long-term
š· Weight gain and diabetes risk ā SGAs
š· QT prolongation possible selected medications
š· NMS rare but life-threatening complication
š Medication Examples & Management
š· Haloperidol potent first-generation antipsychotic
š· Chlorpromazine causes sedation and hypotension
š· Risperidone common second-generation antipsychotic
š· Olanzapine significant metabolic side-effect risk
š· Clozapine requires ANC monitoring regularly
š· Aripiprazole lower metabolic/EPS profile option
𩺠Nursing & Collaborative Management
š· Monitor abnormal movements using AIMS scale
š· Encourage healthy diet and regular exercise
š· Teach adherence despite delayed improvement onset
š· Monitor glucose, lipids, weight routinely
š· Report fever, rigidity, confusion immediately
š· Collaborate psychiatry/pharmacy regarding adverse reactions
1ļøā£0ļøā£8ļøā£ š First-Generation Antipsychotics (FGAs)
š§ Pathophysiology & Core Concepts
š· Strong dopamine D2 receptor blockade mechanism
š· Effective positive psychotic symptom control
š· Higher EPS risk than SGAs
š· Potent antipsychotic effect acute agitation treatment
š· Anticholinergic and sedative effects variable
š· Long-term use risks tardive dyskinesia development
š Monitoring & Adverse Effects
š· Acute dystonia may occur early treatment
š· Akathisia causes intense restlessness sensation
š· Parkinsonism causes rigidity and tremor symptoms
š· Tardive dyskinesia may become irreversible
š· Sedation and orthostatic hypotension possible
š· NMS rare but severe emergency complication
š Medication Examples & Management
š· Haloperidol high-potency common acute psychosis treatment
š· Fluphenazine available long-acting injectable formulation
š· Chlorpromazine low-potency sedating antipsychotic
š· Benztropine treats EPS side effects
š· Diphenhydramine relieves acute dystonia rapidly
š· Dose reduction may improve tolerability issues
𩺠Nursing & Collaborative Management
š· Monitor EPS symptoms routinely each shift
š· Teach patients report stiffness or tremors
š· Encourage hydration and gradual position changes
š· Avoid overheating due anticholinergic effects
š· Assess adherence and psychosis symptom response
š· Collaborate psychiatry for medication adjustments
1ļøā£0ļøā£9ļøā£ š Second-Generation Antipsychotics (SGAs)
š§ Pathophysiology & Core Concepts
š· Block dopamine and serotonin receptors simultaneously
š· Lower EPS risk compared with FGAs
š· Effective positive and some negative symptoms
š· Metabolic side effects major long-term concern
š· Used schizophrenia, bipolar disorder, depression augmentation
š· Clozapine uniquely effective refractory schizophrenia treatment
š Monitoring & Adverse Effects
š· Weight gain and appetite ā common
š· Hyperglycemia and dyslipidemia metabolic risks
š· Sedation and orthostatic hypotension possible
š· QT prolongation risk selected medications
š· Agranulocytosis risk unique clozapine complication
š· Monitor BMI, glucose, lipids routinely
š Medication Examples & Management
š· Risperidone commonly prescribed broad-spectrum SGA
š· Olanzapine high metabolic risk medication
š· Quetiapine sedating bipolar/schizophrenia treatment option
š· Ziprasidone lower weight-gain but QT risk
š· Clozapine requires weekly/periodic ANC monitoring
š· Aripiprazole partial dopamine agonist medication
𩺠Nursing & Collaborative Management
š· Reinforce healthy nutrition and exercise habits
š· Monitor fasting glucose and lipid profile
š· Teach clozapine infection warning signs urgently
š· Assess sedation and fall risk regularly
š· Encourage adherence despite metabolic concerns
š· Collaborate psychiatry and primary-care monitoring
1ļøā£1ļøā£0ļøā£ ā ļø Extrapyramidal Side Effects (EPS)
š§ Pathophysiology & Risk Factors
š· Dopamine blockade in nigrostriatal pathway causes EPS
š· FGAs higher risk than SGAs generally
š· High doses increase EPS development likelihood
š· Young males prone acute dystonia reactions
š· Older women higher tardive dyskinesia risk
š· Long-term antipsychotic exposure major contributor
š Clinical Manifestations & Assessment
š· Acute dystonia: muscle spasm, torticollis, oculogyric crisis
š· Akathisia: pacing, restlessness, inability sit still
š· Parkinsonism: tremor, rigidity, bradykinesia symptoms
š· Tardive dyskinesia: lip-smacking, tongue movements
š· Assess gait, posture, involuntary movements routinely
š· Differentiate EPS from worsening psychosis carefully
š Medical / Therapeutic Management
š· Benztropine treats dystonia and parkinsonism
š· Diphenhydramine effective acute dystonia reversal
š· Propranolol commonly used akathisia treatment
š· Reduce/change antipsychotic if severe EPS
š· VMAT2 inhibitors treat tardive dyskinesia
š· Early detection improves reversibility outcomes
𩺠Nursing & Collaborative Management
š· Monitor movement disorders using AIMS assessment
š· Teach patients report stiffness/restlessness immediately
š· Assess swallowing difficulty during dystonia episodes
š· Promote medication adherence despite side effects
š· Monitor falls and mobility impairment risk
š· Collaborate psychiatry for rapid intervention plans
1ļøā£1ļøā£1ļøā£ ā ļø Neuroleptic Malignant Syndrome
š§ Pathophysiology & Risk Factors
š· Rare life-threatening antipsychotic reaction
š· Dopamine blockade disrupts thermoregulation and muscle control
š· High-potency antipsychotics increase NMS risk
š· Dehydration, agitation, rapid dose increase contribute
š· Can occur with FGAs or SGAs
š· Untreated NMS may cause renal failure/death
š Clinical Manifestations & Assessment
š· Hyperthermia often >38°C, may be severe
š· āLead-pipeā muscle rigidity classic finding
š· Altered mental status, confusion, agitation occur
š· Autonomic instability: BP āā, tachycardia, diaphoresis
š· CK markedly ā from muscle breakdown
š· Leukocytosis and myoglobinuria may appear
š Medical / Emergency Management
š· Stop antipsychotic medication immediately
š· Dantrolene reduces severe muscle rigidity
š· Bromocriptine restores dopamine activity
š· IV fluids prevent renal injury
š· Cooling measures treat hyperthermia urgently
š· ICU monitoring for severe instability
𩺠Nursing & Collaborative Management
š· Report fever + rigidity immediately
š· Monitor temperature, BP, HR, LOC continuously
š· Maintain hydration and monitor urine output
š· Assess CK, renal function, electrolytes
š· Avoid restarting antipsychotics too early
š· Collaborate emergency, psychiatry, ICU team
1ļøā£1ļøā£2ļøā£ š Mood Stabilizers
š§ Pathophysiology & Core Concepts
š· Stabilize manic and depressive mood cycling
š· Used mainly bipolar spectrum disorders
š· Reduce relapse, impulsivity, aggression, suicidality
š· Lithium affects intracellular signaling pathways
š· Anticonvulsants reduce neuronal excitability
š· Serum monitoring prevents toxicity complications
š Monitoring & Adverse Effects
š· Lithium therapeutic level commonly 0.6ā1.2 mEq/L
š· Lithium toxicity risk increases >1.5 mEq/L
š· Valproate may cause hepatotoxicity/thrombocytopenia
š· Carbamazepine may cause agranulocytosis/hyponatremia
š· Lamotrigine may cause Stevens-Johnson syndrome
š· Monitor renal, thyroid, liver, CBC regularly
š Medication Examples & Management
š· Lithium carbonate classic bipolar maintenance therapy
š· Valproic acid useful acute mania
š· Carbamazepine alternative mania treatment
š· Lamotrigine useful bipolar depression prevention
š· Atypical antipsychotics also stabilize mood
š· Avoid abrupt discontinuation, relapse risk ā
𩺠Nursing & Collaborative Management
š· Teach stable sodium and fluid intake
š· Avoid dehydration during lithium therapy
š· Report tremor, vomiting, diarrhea, ataxia
š· Monitor pregnancy risks and contraception needs
š· Reinforce routine lab monitoring adherence
š· Collaborate psychiatry for therapeutic drug monitoring
1ļøā£1ļøā£3ļøā£ ā ļø Lithium Toxicity
š§ Pathophysiology & Risk Factors
š· Lithium has narrow therapeutic index
š· Toxicity occurs with dehydration or overdose
š· Sodium depletion increases lithium reabsorption
š· NSAIDs, ACE inhibitors, diuretics ā levels
š· Renal impairment reduces lithium clearance
š· Severe toxicity can cause seizures/coma
š Clinical Manifestations & Assessment
š· Early: nausea, vomiting, diarrhea, thirst
š· Neurologic: coarse tremor, confusion, ataxia
š· Severe: seizures, dysrhythmias, coma possible
š· Lithium level >1.5 mEq/L concerning
š· Monitor creatinine, BUN, sodium, ECG
š· Assess hydration status and medication interactions
š Medical / Emergency Management
š· Hold lithium immediately if toxicity suspected
š· IV normal saline promotes renal excretion
š· Correct sodium and fluid deficits carefully
š· Hemodialysis severe toxicity/renal failure cases
š· Antiemetics/supportive care for GI symptoms
š· Restart only after provider reassessment
𩺠Nursing & Collaborative Management
š· Teach drink 2ā3 L fluids daily if allowed
š· Maintain consistent salt intake
š· Avoid crash diets and dehydration
š· Report GI upset, tremors, confusion early
š· Monitor lithium levels as scheduled
š· Collaborate prescriber for interacting medications
1ļøā£1ļøā£4ļøā£ š Anticonvulsants in Psychiatry
š§ Pathophysiology & Core Concepts
š· Stabilize neuronal excitability and mood swings
š· Used bipolar disorder, aggression, impulse dyscontrol
š· Some enhance GABA or block sodium channels
š· Useful when lithium ineffective/contraindicated
š· Require laboratory monitoring for toxicity
š· Pregnancy risks vary by medication type
š Monitoring & Adverse Effects
š· Valproate: weight gain, tremor, hepatotoxicity
š· Carbamazepine: dizziness, hyponatremia, agranulocytosis
š· Lamotrigine: rash, Stevens-Johnson syndrome risk
š· Topiramate: cognitive slowing, weight loss possible
š· Monitor CBC, LFTs, sodium when indicated
š· Assess sedation, coordination, mood response
š Medication Examples & Management
š· Valproic acid treats acute mania effectively
š· Divalproex sodium commonly used bipolar disorder
š· Carbamazepine useful mania/impulsivity management
š· Lamotrigine prevents bipolar depressive episodes
š· Topiramate sometimes used off-label supportively
š· Avoid sudden discontinuation, seizure risk possible
𩺠Nursing & Collaborative Management
š· Teach report rash immediately with lamotrigine
š· Monitor liver symptoms with valproate therapy
š· Reinforce adherence and lab follow-up
š· Discuss pregnancy prevention and teratogenic risks
š· Assess dizziness/falls during initiation
š· Collaborate psychiatry and pharmacy monitoring
1ļøā£1ļøā£5ļøā£ š Anxiolytics and Benzodiazepines
š§ Pathophysiology & Core Concepts
š· Enhance GABA inhibitory calming effects
š· Rapidly reduce acute anxiety and agitation
š· Used panic, withdrawal, severe anxiety, insomnia
š· Dependence develops with prolonged use
š· Older adults sensitive to sedation/falls
š· Combining alcohol/opioids increases respiratory depression
š Monitoring & Adverse Effects
š· Sedation, dizziness, slowed reaction time common
š· Respiratory depression possible high dose/combinations
š· Memory impairment and confusion may occur
š· Paradoxical agitation rare but possible
š· Withdrawal causes anxiety, tremors, seizures
š· Assess misuse, tolerance, dependency risk
š Medication Examples & Management
š· Lorazepam useful acute anxiety/agitation
š· Diazepam long-acting withdrawal management
š· Alprazolam rapid panic symptom relief
š· Clonazepam longer-acting panic/anxiety option
š· Buspirone nonbenzodiazepine anxiolytic alternative
š· Taper gradually after prolonged therapy
𩺠Nursing & Collaborative Management
š· Monitor sedation and respiratory status closely
š· Implement fall precautions, especially elderly
š· Teach avoid alcohol, opioids, driving
š· Use short-term lowest effective dose
š· Assess for drug-seeking or misuse behavior
š· Collaborate provider for tapering plans
1ļøā£1ļøā£6ļøā£ š Sedative-Hypnotics
š§ Pathophysiology & Core Concepts
š· Depress CNS activity to promote sleep
š· Used short-term insomnia management only
š· GABA modulation produces sedation and relaxation
š· Tolerance and dependence may develop quickly
š· Older adults risk confusion and falls
š· Long-term use worsens sleep architecture
š Monitoring & Adverse Effects
š· Daytime drowsiness and impaired coordination common
š· Respiratory depression risk ā with alcohol/opioids
š· Memory impairment or parasomnias may occur
š· Rebound insomnia after abrupt discontinuation possible
š· Falls and fractures common elderly complications
š· Assess sleep pattern and medication misuse
š Medication Examples & Management
š· Zolpidem short-term insomnia medication
š· Eszopiclone improves sleep initiation/maintenance
š· Temazepam benzodiazepine hypnotic option
š· Trazodone sometimes used insomnia with depression
š· Melatonin supports circadian rhythm regulation
š· Gradual taper prevents withdrawal/rebound insomnia
𩺠Nursing & Collaborative Management
š· Give medication only when ready for sleep
š· Ensure 7ā8 hours sleep opportunity
š· Teach avoid alcohol and driving
š· Implement fall precautions after dosing
š· Encourage sleep hygiene before medications
š· Collaborate provider for nonpharmacologic options
1ļøā£1ļøā£7ļøā£ š Stimulant Medications for ADHD
š§ Pathophysiology & Core Concepts
š· Increase dopamine/norepinephrine in prefrontal cortex
š· Improve attention, impulse control, task completion
š· First-line medication treatment for ADHD
š· Controlled substances require careful monitoring
š· Effects begin quickly after dosing
š· Misuse/diversion risk especially adolescents/adults
š Monitoring & Adverse Effects
š· Appetite suppression and weight loss common
š· Insomnia occurs if taken late day
š· HR/BP may increase during therapy
š· Tics or anxiety may worsen
š· Growth monitoring important in children
š· Assess misuse, sharing, or overuse
š Medication Examples & Management
š· Methylphenidate common first-line stimulant
š· Amphetamine/dextroamphetamine improves attention symptoms
š· Lisdexamfetamine prodrug lowers misuse potential somewhat
š· Atomoxetine nonstimulant norepinephrine reuptake inhibitor
š· Guanfacine reduces impulsivity/hyperactivity symptoms
š· Give morning dose to reduce insomnia
𩺠Nursing & Collaborative Management
š· Monitor weight, appetite, BP, HR
š· Teach take early in day
š· Encourage breakfast before medication dose
š· Store medication securely to prevent diversion
š· Reinforce behavioral strategies alongside medication
š· Collaborate parents, teachers, prescriber
1ļøā£1ļøā£8ļøā£ š Substance Withdrawal Medications
š§ Pathophysiology & Core Concepts
š· Withdrawal occurs after stopping dependent substance
š· Symptoms reflect CNS rebound or deficiency
š· Alcohol/benzodiazepine withdrawal can be fatal
š· Opioid withdrawal uncomfortable but rarely fatal
š· Medication support reduces complications and relapse
š· Monitoring tools guide safe dosing decisions
š Monitoring & Assessment
š· CIWA-Ar assesses alcohol withdrawal severity
š· COWS assesses opioid withdrawal severity
š· Monitor VS, tremors, agitation, hallucinations
š· Assess seizures, dehydration, electrolyte imbalance
š· Monitor respiratory depression with sedatives/opioids
š· Evaluate suicide risk during withdrawal distress
š Medication Examples & Management
š· Lorazepam/diazepam treat alcohol withdrawal
š· Thiamine prevents Wernicke encephalopathy
š· Buprenorphine reduces opioid withdrawal/cravings
š· Methadone treats opioid dependence/withdrawal
š· Clonidine reduces autonomic opioid withdrawal symptoms
š· Naloxone reverses opioid overdose emergency
𩺠Nursing & Collaborative Management
š· Monitor withdrawal scales per protocol
š· Maintain seizure and fall precautions
š· Encourage hydration and nutrition support
š· Administer thiamine before glucose in alcohol risk
š· Provide nonjudgmental recovery-oriented communication
š· Collaborate addiction medicine and psychiatry
1ļøā£1ļøā£9ļøā£ š Medication Adherence in Psychiatry
š§ Core Concepts & Risk Factors
š· Nonadherence commonly causes relapse and rehospitalization
š· Poor insight reduces perceived medication need
š· Side effects often lead discontinuation
š· Stigma and cost affect adherence
š· Cognitive impairment may impair routine dosing
š· Substance use disrupts treatment consistency
š Assessment & Barriers
š· Ask missed doses without blaming patient
š· Assess side effects and beliefs about medication
š· Evaluate finances, transport, pharmacy access
š· Identify forgetfulness or disorganized routines
š· Review substance use and family support
š· Monitor relapse signs after missed doses
š Management Strategies
š· Simplify regimen when clinically possible
š· Long-acting injectables improve antipsychotic adherence
š· Pill organizers support daily routine
š· Psychoeducation improves insight and cooperation
š· Side-effect management improves tolerability
š· Reminder systems help consistent medication use
𩺠Nursing & Collaborative Management
š· Use motivational interviewing for ambivalence
š· Validate concerns before teaching benefits
š· Teach relapse warning signs and action plan
š· Involve family/supports with patient consent
š· Coordinate medication access and follow-up
š· Collaborate prescriber/pharmacist for adjustments
1ļøā£2ļøā£0ļøā£ š Psychiatric Medication Safety Monitoring
š§ Core Concepts & Risk Factors
š· Psychiatric drugs require ongoing safety surveillance
š· Some medications need serum level monitoring
š· Metabolic syndrome common with SGAs
š· Cardiac conduction changes may occur
š· Pregnancy/lactation require special risk review
š· Polypharmacy increases interaction risk significantly
š Labs & Monitoring
š· Lithium: level, BUN, creatinine, TSH
š· Valproate: LFTs, CBC, serum level
š· Carbamazepine: CBC, sodium, LFTs
š· Clozapine: ANC monitoring mandatory
š· SGAs: weight, glucose, lipids, BP
š· QT-risk drugs: ECG and electrolytes
š Safety Management
š· Adjust doses based on labs/response
š· Hold medication for severe toxicity signs
š· Avoid interacting OTC/herbal substances
š· Use lowest effective dose when possible
š· Taper medications when discontinuing long-term
š· Emergency treatment needed severe reactions
𩺠Nursing & Collaborative Management
š· Track baseline and follow-up labs
š· Teach patients which symptoms need reporting
š· Monitor adherence and side effects regularly
š· Encourage carrying medication list always
š· Communicate abnormal findings promptly
š· Collaborate psychiatry, pharmacy, primary care
1ļøā£2ļøā£1ļøā£ š ļø Psychotherapy Overview
š§ Core Concepts & Principles
š· Structured therapeutic interaction improves mental health
š· Targets thoughts, emotions, behaviors, relationships, coping
š· Can be individual, group, family, couples format
š· Often combined with pharmacologic treatment approaches
š· Requires trust, rapport, therapeutic communication
š· Evidence-based therapies improve long-term outcomes
š Assessment & Therapeutic Focus
š· Identify stressors, coping skills, maladaptive behaviors
š· Assess insight, motivation, emotional regulation abilities
š· Evaluate trauma history and support systems
š· Determine suicide/self-harm risk during sessions
š· Monitor treatment participation and progress goals
š· Assess barriers: stigma, cost, transportation, culture
š Therapeutic Modalities & Management
š· CBT targets distorted thinking and behaviors
š· DBT improves emotional regulation and distress tolerance
š· Psychodynamic therapy explores unconscious conflicts
š· Exposure therapy treats anxiety and PTSD
š· Family therapy improves communication and support
š· Group therapy enhances peer learning/accountability
𩺠Nursing & Collaborative Management
š· Use active listening and empathy consistently
š· Maintain confidentiality and professional boundaries
š· Encourage participation and realistic goal-setting
š· Reinforce coping strategies learned in therapy
š· Monitor emotional response after difficult sessions
š· Collaborate therapists, psychiatrists, social workers
1ļøā£2ļøā£2ļøā£ š§ Cognitive Behavioral Therapy (CBT)
š§ Pathophysiology & Core Concepts
š· Thoughts influence emotions and behaviors directly
š· Distorted thinking patterns worsen psychiatric symptoms
š· CBT restructures maladaptive thought processes
š· Present-focused and goal-oriented therapy style
š· Effective depression, anxiety, PTSD, OCD treatment
š· Homework reinforces coping outside therapy sessions
š Assessment & Therapeutic Focus
š· Identify automatic negative thoughts and beliefs
š· Assess cognitive distortions affecting behavior/emotions
š· Monitor avoidance and maladaptive coping patterns
š· Evaluate symptom triggers and behavioral responses
š· Assess progress using measurable goals
š· Encourage self-monitoring journals or worksheets
š CBT Interventions & Management
š· Cognitive restructuring challenges irrational beliefs
š· Behavioral activation improves depressive withdrawal symptoms
š· Exposure techniques reduce anxiety avoidance patterns
š· Relaxation training lowers physiologic stress response
š· Problem-solving skills improve coping effectiveness
š· Homework assignments reinforce therapy gains
𩺠Nursing & Collaborative Management
š· Encourage identifying triggers and thought patterns
š· Reinforce realistic positive self-statements
š· Support gradual exposure to feared situations
š· Promote consistent therapy attendance and homework
š· Validate emotional distress while challenging distortions
š· Collaborate therapists regarding patient progress
1ļøā£2ļøā£3ļøā£ š§ Dialectical Behavior Therapy (DBT)
š§ Pathophysiology & Core Concepts
š· Developed primarily borderline personality disorder treatment
š· Combines acceptance and behavioral change strategies
š· Targets emotional dysregulation and impulsive behaviors
š· Reduces self-harm and suicidal behaviors effectively
š· Mindfulness central DBT therapeutic principle
š· Structured skills-training based psychotherapy approach
š Assessment & Therapeutic Focus
š· Assess self-harm urges and emotional triggers
š· Monitor impulsive or high-risk behaviors
š· Evaluate interpersonal conflict and coping deficits
š· Assess distress tolerance during crises
š· Monitor therapy attendance and skill utilization
š· Evaluate suicidal ideation routinely
š DBT Skills & Management
š· Mindfulness improves present-moment awareness
š· Distress tolerance reduces crisis impulsivity
š· Emotion regulation improves mood stability
š· Interpersonal effectiveness strengthens relationships
š· Diary cards track emotions and behaviors
š· Telephone coaching supports crisis management
𩺠Nursing & Collaborative Management
š· Reinforce DBT coping skills consistently
š· Validate emotions without reinforcing maladaptive behavior
š· Encourage mindfulness and grounding exercises
š· Maintain firm therapeutic boundaries always
š· Support use of crisis-survival strategies
š· Collaborate DBT team and outpatient supports
1ļøā£2ļøā£4ļøā£ šØāš©āš§ Family Therapy
š§ Core Concepts & Principles
š· Family dynamics strongly affect mental health outcomes
š· Dysfunctional communication may worsen psychiatric symptoms
š· Therapy focuses system rather than individual alone
š· Improves support, boundaries, conflict resolution
š· Family psychoeducation reduces relapse rates
š· Cultural beliefs influence family interactions significantly
š Assessment & Therapeutic Focus
š· Assess communication patterns and conflict areas
š· Identify caregiver burden and coping deficits
š· Evaluate enabling or codependent behaviors
š· Assess trauma, abuse, unresolved grief history
š· Monitor family understanding of mental illness
š· Identify strengths and support resources
š Therapeutic Interventions & Management
š· Psychoeducation improves illness understanding/adherence
š· Communication training reduces family conflict
š· Problem-solving strategies improve coping effectiveness
š· Boundary-setting prevents maladaptive dependency patterns
š· Supportive therapy improves emotional expression
š· Crisis planning strengthens family preparedness
𩺠Nursing & Collaborative Management
š· Encourage respectful open family communication
š· Reinforce realistic expectations and shared goals
š· Support caregivers experiencing burnout/stress
š· Maintain patient confidentiality and consent rights
š· Teach relapse warning signs and interventions
š· Collaborate family therapists and community resources
1ļøā£2ļøā£5ļøā£ š„ Group Therapy & Milieu Therapy
š§ Core Concepts & Principles
š· Group interaction promotes learning and support
š· Therapeutic milieu uses environment for healing
š· Peer feedback enhances insight and accountability
š· Structured routines improve emotional stability
š· Socialization reduces isolation and stigma
š· Safe environment essential therapeutic effectiveness
š Assessment & Therapeutic Focus
š· Assess participation and communication patterns
š· Monitor group dynamics and conflict triggers
š· Evaluate social skills and coping behaviors
š· Identify withdrawal or disruptive participation
š· Assess safety risks within group setting
š· Monitor response to therapeutic environment
š Therapeutic Interventions & Management
š· Psychoeducational groups teach illness management
š· Support groups provide emotional validation
š· Activity therapy improves social engagement
š· Milieu structure reinforces healthy behaviors
š· Community meetings improve responsibility/accountability
š· Behavioral contracts support treatment goals
𩺠Nursing & Collaborative Management
š· Maintain safe respectful therapeutic environment
š· Encourage participation without forcing disclosure
š· Set clear behavioral expectations consistently
š· Reinforce positive peer interactions appropriately
š· Monitor escalation or bullying behaviors
š· Collaborate interdisciplinary treatment team regularly
1ļøā£2ļøā£6ļøā£ ā” Crisis Intervention
š§ Core Concepts & Pathophysiology
š· Crisis occurs when coping mechanisms overwhelmed
š· Acute stress impairs judgment and problem-solving
š· Can be situational, maturational, or psychiatric
š· Crisis state usually temporary but high-risk
š· Suicide and violence risk may rapidly escalate
š· Early intervention prevents long-term psychological deterioration
š Assessment & Clinical Manifestations
š· Anxiety, panic, confusion commonly present
š· Poor concentration and impulsive decisions possible
š· Sleep disturbance and emotional instability occur
š· Assess suicidal/homicidal ideation immediately
š· Determine precipitating event and support systems
š· Evaluate coping skills and substance use
š Crisis Management & Therapeutic Interventions
š· Ensure immediate safety and stabilization priority
š· Use brief focused goal-directed intervention
š· Problem-solving strategies improve coping ability
š· Benzodiazepines may reduce severe acute agitation
š· Hospitalization if danger to self/others present
š· Referral to long-term therapy after stabilization
𩺠Nursing & Collaborative Management
š· Maintain calm supportive nonjudgmental communication
š· Use active listening and reassurance techniques
š· Reduce environmental stimuli during escalation
š· Encourage expression of emotions safely
š· Develop short-term realistic action plan
š· Collaborate crisis team and community resources
1ļøā£2ļøā£7ļøā£ šØ Suicide Risk Assessment & Prevention
š§ Pathophysiology & Risk Factors
š· Suicide associated hopelessness and psychological pain
š· Depression strongest psychiatric suicide risk factor
š· Prior attempts major predictor future suicide
š· Substance abuse increases impulsive suicide behavior
š· Access to lethal means increases completion risk
š· Social isolation and trauma worsen vulnerability
š Clinical Manifestations & Assessment
š· Verbal clues: ābetter off deadā statements
š· Giving away possessions concerning warning sign
š· Sudden calmness after severe depression possible
š· Assess plan, intent, means, timeframe directly
š· Evaluate protective factors and support systems
š· Monitor self-harm behavior and hopelessness severity
š Emergency / Therapeutic Management
š· Suicide precautions if high-risk identified
š· Remove sharp objects, cords, medications immediately
š· One-to-one observation severe imminent risk cases
š· Antidepressants and therapy treat underlying illness
š· Crisis hotlines and safety plans essential
š· Hospitalization required severe active suicidal intent
𩺠Nursing & Collaborative Management
š· Ask directly about suicidal thoughts calmly
š· Do not leave high-risk patient alone
š· Maintain therapeutic hopeful communication approach
š· Document suicidal statements and interventions accurately
š· Involve support system with patient consent
š· Collaborate psychiatry and crisis intervention teams
1ļøā£2ļøā£8ļøā£ ā ļø Violence & Aggression Management
š§ Pathophysiology & Risk Factors
š· Aggression may result psychosis, mania, intoxication
š· Fear and overstimulation can trigger violence
š· History violence strongest future violence predictor
š· Substance use significantly increases aggression risk
š· Impulsivity and paranoia worsen dangerous behavior
š· Escalation often follows predictable behavioral patterns
š Clinical Manifestations & Assessment
š· Pacing, clenched fists, loud speech warning signs
š· Verbal threats and agitation may escalate rapidly
š· Paranoia and command hallucinations increase risk
š· Assess access to weapons immediately
š· Evaluate triggers and de-escalation response
š· Monitor staff/patient safety continuously
š Emergency / Therapeutic Management
š· Verbal de-escalation first-line intervention approach
š· PRN antipsychotics/benzodiazepines severe agitation cases
š· Seclusion/restraints only last resort measures
š· Low-stimulation environment decreases escalation triggers
š· Rapid tranquilization if imminent harm risk
š· Team response protocols improve safety outcomes
𩺠Nursing & Collaborative Management
š· Maintain calm nonthreatening body language
š· Keep safe distance and exit access
š· Use short simple clear communication
š· Avoid arguing or sudden physical contact
š· Call assistance early during escalation
š· Debrief patient/staff after aggressive incident
1ļøā£2ļøā£9ļøā£ ā” Electroconvulsive Therapy (ECT)
š§ Pathophysiology & Core Concepts
š· Controlled seizure induced under anesthesia
š· Alters neurotransmitter pathways improving severe symptoms
š· Effective severe depression and catatonia treatment
š· Rapid response useful suicidal depression crises
š· Modern ECT safer than historical procedures
š· Temporary memory impairment common adverse effect
š Assessment & Monitoring
š· Assess cardiac and airway status pre-ECT
š· Baseline memory and cognition documented
š· NPO status required before procedure
š· Monitor confusion and headache post-treatment
š· Observe VS and oxygenation closely afterward
š· Assess return of orientation post-anesthesia
š Procedure & Therapeutic Management
š· Methohexital/propofol used procedural anesthesia
š· Succinylcholine provides muscle relaxation
š· Oxygenation maintained throughout treatment process
š· Series commonly 6ā12 sessions total
š· Bilateral ECT more effective but memory risk ā
š· Maintenance ECT sometimes prevents relapse
𩺠Nursing & Collaborative Management
š· Verify consent and preprocedure preparation
š· Remove dentures, jewelry, contact lenses
š· Reorient patient calmly after procedure
š· Monitor aspiration and fall risk
š· Educate temporary memory loss expectations
š· Collaborate psychiatry and anesthesia providers
1ļøā£3ļøā£0ļøā£ š§ Trauma-Informed Care
š§ Core Concepts & Pathophysiology
š· Trauma affects emotional and physiologic regulation
š· Past abuse may influence healthcare interactions
š· Safety and trust central trauma-informed approach
š· Retraumatization worsens psychiatric distress significantly
š· Trauma may alter stress-response neurobiology
š· Empowerment improves treatment engagement and recovery
š Assessment & Clinical Focus
š· Assess trauma history sensitively and respectfully
š· Monitor triggers causing fear or dissociation
š· Observe hypervigilance and avoidance behaviors
š· Evaluate coping mechanisms and support systems
š· Assess current safety from abuse/violence
š· Respect patient boundaries and preferences consistently
š Therapeutic / Supportive Management
š· Trauma-focused CBT supports trauma processing
š· EMDR assists distressing memory desensitization
š· SSRIs may reduce PTSD/anxiety symptoms
š· Grounding techniques reduce dissociation episodes
š· Crisis stabilization during acute trauma reactions
š· Support groups decrease shame and isolation
𩺠Nursing & Collaborative Management
š· Ask permission before touch or procedures
š· Use calm predictable respectful communication always
š· Avoid blaming or judgmental statements
š· Promote patient choice and control whenever possible
š· Reinforce coping and grounding strategies
š· Collaborate trauma specialists and support services
1ļøā£3ļøā£1ļøā£ š§ Behavioral Therapy
š§ Core Concepts & Pathophysiology
š· Behavior learned through reinforcement and conditioning
š· Maladaptive behaviors can be modified systematically
š· Focuses observable behaviors rather than unconscious conflict
š· Rewards strengthen desired adaptive behaviors
š· Avoidance behaviors reinforce anxiety disorders
š· Repetition improves long-term behavioral change patterns
š Assessment & Clinical Focus
š· Identify triggers and reinforcing consequences
š· Assess maladaptive coping and avoidance behaviors
š· Monitor behavioral frequency and intensity trends
š· Evaluate motivation and readiness for change
š· Assess environmental influences on behavior
š· Determine measurable treatment goals clearly
š Therapeutic / Behavioral Management
š· Positive reinforcement encourages adaptive behavior repetition
š· Exposure therapy reduces phobic avoidance gradually
š· Aversion therapy discourages harmful behaviors
š· Token economies reinforce treatment participation
š· Systematic desensitization lowers anxiety responses
š· Behavioral contracts improve accountability and structure
𩺠Nursing & Collaborative Management
š· Reinforce positive behaviors consistently immediately
š· Avoid unintentionally rewarding maladaptive actions
š· Use clear expectations and structured routines
š· Monitor response to behavioral interventions regularly
š· Encourage gradual exposure during anxiety treatment
š· Collaborate therapists and behavioral specialists
1ļøā£3ļøā£2ļøā£ š§ Exposure Therapy
š§ Core Concepts & Pathophysiology
š· Gradual exposure decreases fear response over time
š· Avoidance maintains anxiety and phobic behaviors
š· Repeated exposure promotes habituation process
š· Effective PTSD, OCD, phobia treatment modality
š· Anxiety initially rises before gradual reduction
š· Controlled environment improves therapeutic safety
š Assessment & Clinical Focus
š· Identify feared triggers and avoidance patterns
š· Assess physiologic anxiety symptoms during exposure
š· Determine hierarchy from mild ā severe triggers
š· Monitor panic, dissociation, emotional tolerance levels
š· Evaluate coping skills before initiating therapy
š· Assess motivation and treatment adherence barriers
š Therapeutic / Behavioral Management
š· Gradual exposure builds tolerance to anxiety
š· Flooding uses prolonged intense exposure rarely
š· Virtual-reality exposure available selected disorders
š· Response prevention critical OCD treatment component
š· Relaxation techniques support exposure participation
š· Repeated practice prevents relapse recurrence
𩺠Nursing & Collaborative Management
š· Support patient during exposure exercises calmly
š· Reinforce coping strategies and breathing techniques
š· Avoid allowing complete avoidance behaviors
š· Encourage gradual progress without rushing therapy
š· Monitor severe distress or dissociation signs
š· Collaborate therapists for exposure planning
1ļøā£3ļøā£3ļøā£ š§ Psychoanalysis & Psychodynamic Therapy
š§ Core Concepts & Pathophysiology
š· Explores unconscious conflicts influencing behavior/emotions
š· Early childhood experiences shape personality patterns
š· Insight improves emotional understanding and coping
š· Defense mechanisms protect against anxiety unconsciously
š· Transference may occur within therapeutic relationship
š· Long-term therapy common traditional psychoanalysis
š Assessment & Clinical Focus
š· Assess recurring interpersonal and emotional patterns
š· Identify defense mechanisms and unresolved conflicts
š· Explore dreams, memories, emotional reactions
š· Evaluate relationship difficulties and attachment issues
š· Monitor transference and countertransference dynamics
š· Assess insight and emotional tolerance capacity
š Therapeutic / Supportive Management
š· Free association explores unconscious thoughts freely
š· Interpretation links behaviors with unconscious conflicts
š· Dream analysis examines symbolic unconscious meaning
š· Insight-oriented therapy improves self-awareness
š· Emotional expression encouraged within safe environment
š· Long-term consistent sessions enhance therapeutic progress
𩺠Nursing & Collaborative Management
š· Maintain therapeutic neutrality and boundaries
š· Encourage exploration of feelings and experiences
š· Avoid giving direct advice excessively
š· Monitor emotional distress during deep exploration
š· Support patient insight and coping development
š· Collaborate psychotherapists and mental-health team
1ļøā£3ļøā£4ļøā£ š§ Mindfulness & Relaxation Therapies
š§ Core Concepts & Pathophysiology
š· Mindfulness promotes present-moment awareness nonjudgmentally
š· Stress activates sympathetic nervous system excessively
š· Relaxation therapies reduce physiologic stress responses
š· Breathing control lowers autonomic hyperarousal
š· Chronic stress worsens psychiatric and medical illness
š· Regular practice improves emotional regulation resilience
š Assessment & Clinical Focus
š· Assess stress triggers and coping habits
š· Monitor anxiety, tension, sleep disturbance severity
š· Evaluate readiness for relaxation participation
š· Identify barriers to regular practice routines
š· Assess concentration and emotional regulation ability
š· Monitor physiologic signs during relaxation exercises
š Therapeutic / Supportive Management
š· Deep breathing reduces acute anxiety symptoms
š· Progressive muscle relaxation lowers muscle tension
š· Guided imagery promotes calm mental focus
š· Meditation improves emotional regulation and attention
š· Yoga combines breathing and body awareness
š· Mindfulness reduces relapse depression/anxiety disorders
𩺠Nursing & Collaborative Management
š· Teach slow diaphragmatic breathing techniques
š· Provide quiet low-stimulation environment during exercises
š· Encourage regular daily mindfulness practice
š· Reinforce relaxation before stressful procedures/events
š· Monitor reduction anxiety and physiologic tension
š· Collaborate therapy and wellness programs
1ļøā£3ļøā£5ļøā£ šļø Psychiatric Rehabilitation & Recovery Model
š§ Core Concepts & Pathophysiology
š· Recovery emphasizes meaningful life despite illness
š· Focuses strengths rather than deficits alone
š· Chronic psychiatric illness may impair functioning
š· Social support improves recovery outcomes significantly
š· Hope and autonomy central recovery principles
š· Rehabilitation enhances independent community functioning
š Assessment & Clinical Focus
š· Assess ADLs and occupational functioning ability
š· Evaluate housing, employment, social support needs
š· Identify patient goals and personal strengths
š· Monitor relapse patterns and adherence barriers
š· Assess substance use and community resources
š· Evaluate quality-of-life and recovery progress
š Therapeutic / Rehabilitation Management
š· Vocational rehabilitation supports employment readiness
š· Social-skills training improves interpersonal functioning
š· ACT teams support severe persistent illness
š· Peer-support programs enhance recovery engagement
š· Psychoeducation improves illness self-management
š· Supported housing promotes community stability
𩺠Nursing & Collaborative Management
š· Encourage patient participation in goal-setting
š· Promote independence and self-care skills
š· Reinforce medication adherence and relapse prevention
š· Support community reintegration and socialization
š· Advocate access mental-health community resources
š· Collaborate rehab specialists and support agencies
1ļøā£3ļøā£6ļøā£ š¤ Motivational Interviewing
š§ Core Concepts & Pathophysiology
š· Patient-centered counseling strengthens internal motivation
š· Ambivalence is normal during behavior change
š· Autonomy improves honesty and treatment engagement
š· Confrontation may increase resistance and defensiveness
š· Readiness to change varies by stage
š· Commonly used addiction and lifestyle change
š Assessment & Clinical Focus
š· Assess readiness, importance, and confidence levels
š· Explore ambivalence without judgment or pressure
š· Identify patient values and personal goals
š· Listen for change talk and sustain talk
š· Assess barriers, triggers, and support systems
š· Monitor relapse risk and coping ability
š Therapeutic / Supportive Management
š· OARS: open questions, affirmations, reflections, summaries
š· Decisional balance explores pros and cons
š· Elicit change talk through guided questions
š· Support self-efficacy and patient choice
š· Avoid arguing, lecturing, or shaming
š· Develop realistic patient-owned action plan
𩺠Nursing & Collaborative Management
š· Ask permission before giving advice
š· Reflect feelings and patient statements accurately
š· Affirm strengths and previous successes
š· Collaboratively set small achievable goals
š· Reinforce progress even after relapse
š· Collaborate addiction and counseling services
1ļøā£3ļøā£7ļøā£ š§ Trauma-Informed Care
š§ Core Concepts & Pathophysiology
š· Trauma affects emotional regulation and trust
š· Past abuse may shape healthcare responses
š· Safety and choice reduce retraumatization risk
š· Hypervigilance reflects altered stress-response system
š· Dissociation may occur during perceived threat
š· Empowerment supports recovery and engagement
š Assessment & Clinical Focus
š· Assess trauma history only when appropriate
š· Watch triggers causing panic or withdrawal
š· Observe dissociation, hypervigilance, avoidance behaviors
š· Evaluate current safety and support systems
š· Assess self-harm and suicide risk
š· Identify patient preferences for care interactions
š Therapeutic / Supportive Management
š· Grounding techniques reduce dissociation symptoms
š· Trauma-focused CBT supports trauma processing
š· EMDR helps desensitize traumatic memories
š· SSRIs may reduce PTSD/anxiety symptoms
š· Crisis stabilization prioritizes immediate safety
š· Peer support decreases shame and isolation
𩺠Nursing & Collaborative Management
š· Ask permission before touch or procedures
š· Use calm predictable respectful communication
š· Offer choices whenever safely possible
š· Avoid blaming, pressuring, or minimizing experiences
š· Maintain privacy, dignity, and boundaries
š· Collaborate trauma specialists and advocacy services
1ļøā£3ļøā£8ļøā£ š„ Psychiatric Rehabilitation
š§ Core Concepts & Pathophysiology
š· Rehabilitation improves function despite chronic illness
š· Focuses skills, independence, and community participation
š· Severe mental illness may impair ADLs
š· Functional recovery differs from symptom remission
š· Social isolation worsens psychiatric disability
š· Strength-based care supports long-term recovery
š Assessment & Clinical Focus
š· Assess ADLs, work, housing, relationships
š· Evaluate medication adherence and relapse triggers
š· Identify patient goals and strengths
š· Assess cognitive deficits affecting independence
š· Monitor substance use and safety risks
š· Evaluate family and community support availability
š Therapeutic / Rehabilitation Management
š· Skills training improves daily functioning
š· Supported employment promotes work participation
š· Supported housing reduces relapse/homelessness risk
š· Social skills training improves relationships
š· Psychoeducation supports illness self-management
š· Case management coordinates long-term services
𩺠Nursing & Collaborative Management
š· Encourage independence in self-care tasks
š· Reinforce realistic goal-setting and progress
š· Teach relapse prevention and medication routines
š· Support community reintegration and socialization
š· Advocate for housing, benefits, resources
š· Collaborate rehab, social work, community agencies
1ļøā£3ļøā£9ļøā£ šļø Community-Based Mental Health Programs
š§ Core Concepts & Pathophysiology
š· Community care reduces unnecessary hospitalization
š· Supports recovery in patientās living environment
š· Chronic illness needs continuity and access
š· Social determinants affect mental health outcomes
š· Stigma and poverty limit treatment engagement
š· Integrated care improves psychiatric and physical health
š Assessment & Community Focus
š· Assess housing stability and food security
š· Evaluate medication access and transportation barriers
š· Monitor relapse warning signs in community
š· Assess family support and caregiver burden
š· Screen suicide, substance use, violence risk
š· Identify need for crisis or outreach services
š Program / Service Management
š· ACT provides intensive community-based support
š· Case management links services and resources
š· Day programs promote structure/socialization
š· Peer support improves engagement and hope
š· Crisis hotlines/mobile teams provide urgent help
š· Integrated clinics coordinate mental/physical healthcare
𩺠Nursing & Collaborative Management
š· Reinforce follow-up and medication adherence
š· Teach relapse action plans clearly
š· Coordinate referrals and community resources
š· Support caregiver education and coping
š· Encourage peer and support-group participation
š· Collaborate LGU, social services, mental-health teams
1ļøā£4ļøā£0ļøā£ š± Recovery-Oriented Psychiatric Care
š§ Core Concepts & Pathophysiology
š· Recovery emphasizes hope, empowerment, self-direction
š· Patient defines meaningful goals and success
š· Focus extends beyond symptom elimination
š· Strengths-based care promotes dignity and autonomy
š· Relapse can occur without recovery failure
š· Supportive relationships improve long-term outcomes
š Assessment & Clinical Focus
š· Identify patient strengths, values, priorities
š· Assess barriers to personal recovery goals
š· Monitor symptom burden and functional progress
š· Evaluate social support and community connection
š· Assess stigma, shame, and self-efficacy
š· Review relapse triggers and coping plans
š Therapeutic / Supportive Management
š· Shared decision-making improves treatment engagement
š· Wellness recovery action plan guides coping
š· Peer support promotes hope and belonging
š· Psychoeducation improves illness self-management
š· Vocational/social rehabilitation supports meaningful roles
š· Relapse prevention planning protects stability
𩺠Nursing & Collaborative Management
š· Use respectful person-first recovery language
š· Encourage active participation in care planning
š· Reinforce strengths and achievements consistently
š· Support autonomy while maintaining safety
š· Promote community reintegration and meaningful activities
š· Collaborate interdisciplinary recovery support network
Effective psychiatric treatment requires integration of psychopharmacology, psychotherapy, behavioral interventions, rehabilitation, crisis management, and long-term recovery support to address the biologic, psychological, emotional, behavioral, and social dimensions of mental illness. Nurses play a major role in medication administration, safety monitoring, suicide prevention, therapeutic communication, patient education, behavioral management, relapse prevention, trauma-informed care, and interdisciplinary coordination across all psychiatric settings. Mastery of psychiatric medications and therapies strengthens clinical judgment in recognizing medication toxicities, treatment responses, psychiatric emergencies, behavioral escalation, adherence barriers, and psychosocial needs while promoting patient safety, stabilization, functional recovery, and holistic mental health care.

Comments